Page 237 - Aet News Today

Telemedicine company TytoCare launched a new offering that promises to give providers and health plans the range of products and services needed to operate successful virtual primary care programs. Gilad said the offering, named Home Smart Clinic, can give customers a clear picture of ROI because of its high utilization and patient engagement rates.

With these APIs, data scientists, developers and analysts can free themselves from frustrating, tedious, and manual efforts to code and clean unstructured data. This is particularly valuable in healthcare where as much as 80% data is locked in unstructured text.

A customer of Cost Plus Drugs received an email from the company in October stating that “due to skyrocketing demand,” shipping times have been delayed. Marley Drug, a competitor, said its company has not experienced delays and presented itself as an alternative for Americans.

Amgen posted positive Phase 2 data for olpasiran, further building the case for the drug's blockbuster potential in heart disease as it proceeds to a pivotal test. Arrowhead Pharmaceuticals, which originally developed olpasiran and licensed it to the big pharma company, is cashing in now by selling its royalty rights to the molecule.

Though the case started small, it has gained national attention and more than a dozen states have submitted an amicus brief in support of the Health and Hospital Corporation that operates 78 nursing facilities across Indiana.

Insurers and employers are optimistic about the possibilities of virtual care, but they're not very enthusiastic about the care modality's larger influence on the healthcare industry, according to a recent report. Just 29% of employers and 34% of payers and benefits consultants said that virtual care will drastically change the way healthcare is provided and outcomes are achieved.

The product — available January 1 — combines Headspace’s meditation and mindfulness services with Ginger’s coaching, therapy and psychiatry services. It also gives employers insights on their employees' engagement and outcomes.

Two years after the close of the merger that formed Viatris, the company is acquiring Oyster Point Pharma and Famy Life Sciences to expand its scope in ophthalmology, one of three therapeutic areas it is now focusing on for revenue growth.

The combined organization will have more than 680 provider locations in 26 markets. With CVS Health and Amazon both making major acquisitions, the Summit Health deal was both offensive and defensive for Walgreens, one expert said.

In order to provide quality pediatric care, children’s hospitals need more government support, Children’s Hospital Association CEO Mark Wietecha argued in a recent letter to Congress. He recommended Congress enact 12-month continuous eligibility for children covered by Medicaid or CHIP, allocate more money to pediatric physician training, and enhance Medicaid's low reimbursement rates for pediatric care.